CoChat

Effects of Changing From Typical to Atypical Antipsychotic Drugs on Subjective Sleep Quality in Patients With Schizophrenia in a Japanese Population

Yamashita, Hidehisa, Mori, Kazuhiko, Nagao, Masatsugu, Okamoto, Yasumasa, Morinobu, Shigeru, Yamawaki, Shigeto · 2004 · The Journal of Clinical Psychiatry

The DOI matches its Crossref record.

Abstract

OBJECTIVE: To investigate the effects of the atypical antipsychotic drugs risperidone, olanzapine, quetiapine, and perospirone on the subjective quality of sleep in patients with schizophrenia. METHOD: Subjects were 92 inpatients (mean age = 59.9 years) who had been receiving treatment with conventional antipsychotic drugs and who met the DSM-IV criteria for schizophrenia. Subjects were randomly assigned to receive 1 of 4 atypical antipsychotic drugs (olanzapine, perospirone, quetiapine, and risperidone). Subjective sleep quality and psychopathology were assessed twice: at baseline and 8 weeks after switching. Data were collected from June 2001 to December 2001. Subjective sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI), and psychopathology was measured by the Positive and Negative Syndrome Scale (PANSS). RESULTS: Subjective sleep quality as assessed by the PSQI was significantly improved with administration of olanzapine, risperidone, or quetiapine, but not with perospirone, in comparison with conventional antipsychotic drugs. Multiple regression analysis revealed that the improvement of sleep quality with administration of atypical antipsychotic drugs was predicted by poor sleep quality at baseline. In addition, improvement of sleep quality was significantly correlated with improvement of negative symptoms as assessed by the PANSS. CONCLUSION: These results demonstrated that atypical antipsychotic drugs improved subjective quality of sleep in patients with schizophrenia compared with conventional antipsychotic drugs, suggesting that the marked potency of serotonin-2 receptor blockade in atypical antipsychotic drugs may be involved in the mechanism of this improvement. These improvements were correlated with improvement of negative symptoms.

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.v65n1114

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

See all 46

Metadata

Authors
Yamashita, H., Mori, K., Nagao, M., Okamoto, Y., Morinobu, S., & Yamawaki, S.
Affiliations
Hiroshima University (JP)
Venue
The Journal of Clinical Psychiatry
Published
2004-11-15
Volume
65
Issue
11
Pages
1525-1530
ISSN
0160-6689 (ISSN-L)
OpenAlex
W1987549938
Cited by
46
References
0
Citations by year
2026: 3 · 2025: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 2
FWCI
1.66
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
atypical antipsychotics, schizophrenia, subjective sleep quality, risperidone, olanzapine, quetiapine, perospirone, typical antipsychotics, negative symptoms, antipsychotic switching, psychopathology
MeSH terms
Quetiapine Fumarate, Olanzapine, Adult, Aged, Benzodiazepines, Dibenzothiazepines, Drug Administration Schedule, Female, Health Status, Hospitalization, Humans, Indoles, Japan, Male, Middle Aged, Psychiatric Status Rating Scales, Regression Analysis, Schizophrenia, Schizophrenic Psychology, Severity of Illness Index, Sleep, Thiazoles, Antipsychotic Agents, Risperidone, Isoindoles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.